High concentration antibody and protein formulations

Details for Australian Patent Application No. 2004229335 (hide)

Owner Genentech, Inc. Novartis AG

Inventors Shire, Steven; Liu, Jun

Agent Griffith Hack

Pub. Number AU-B-2004229335

PCT Pub. Number WO2004/091658

Priority 60/460,659 04.04.03 US

Filing date 29 March 2004

Wipo publication date 28 October 2004

Acceptance publication date 3 December 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/091658 Priority application(s): WO2004/091658

3 December 2009 Application Accepted

  Published as AU-B-2004229335

25 February 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 03 Feb 2010. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004

17 June 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Feb 2010

17 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229336-Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives

2004229330-Soya or grain fiber particulates and methods of preparation